← Back to Search

Antioxidant

Placebo for Pharmacokinetics

N/A

Recruiting

Led By Gitte Jensen, PhD

Research Sponsored by Natural Immune Systems Inc

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Willing to avoid consumption of meals where the predominant ingredients include mushrooms, seafood, and organ meat (liver, heart).

Willing to abstain from music, candy, gum, computer/cell phone use, during clinic visits.

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 1 week

Awards & highlights

Study Summary

This trial looks at whether a new blend of nutrients can help protect against illness and improve immunity.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

You must avoid eating meals that contain mushrooms, seafood, liver, or heart.

Select...

You won't be allowed to use your cell phone, listen to music, eat candy, or chew gum during visits to the clinic.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 1 week

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~1 week

This trial's timeline: 3 weeks for screening, Varies for treatment, and 1 week for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Other outcome measures

Change in level of reduced glutathione

Change in mitochondrial mass and mitochondrial potential from baseline

Trial Design

1Treatment groups

Experimental Treatment

Group I: Placebo, Ergothioneine 25mg, Ergothioneine 25mg for 1 week dailyExperimental Treatment3 Interventions

Participants will consume placebo on first study day, consume 25mg of ergothioneine on second study day, then consume 25mg of ergothioneine daily for 1 week

Treatment

First Studied

Drug Approval Stage

How many patients have taken this drug

Placebo

1995

Completed Phase 3

~2670

0 / 2Eligibility criteria met

Find a Location

Who is running the clinical trial?

Natural Immune Systems IncLead Sponsor

18 Previous Clinical Trials

463 Total Patients Enrolled

2 Trials studying Pharmacokinetics

48 Patients Enrolled for Pharmacokinetics

Gitte Jensen, PhDPrincipal InvestigatorNIS Labs

4 Previous Clinical Trials

102 Total Patients Enrolled

1 Trials studying Pharmacokinetics

24 Patients Enrolled for Pharmacokinetics

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is it possible to become a participant in this clinical experiment?

"This clinical trial seeks 24 participants with pharmacokinetics and an age range between 18-75 years old."

Answered by AI

How many individuals have signed up to take part in this clinical experiment?

"Affirmative. According to clinicaltrials.gov, this clinical trial was initially posted on the 20th of September 2021 and most recently modified on the 7th of June 2022. It is currently seeking 24 participants from 1 site for enrollment."

Answered by AI

Is this research study open to volunteers at the present time?

"According to the listing on clinicaltrials.gov, this study is still open and recruiting patients; it initially went live on September 20th 2021 with its latest update being recorded as June 7th 2022."

Answered by AI

Does this clinical trial include elderly participants?

"The eligibility requirements for this study specifies that participants must fall between the ages of 18 to 75. For those under 18 or over 65, there are 3 and 28 trials respectively."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Clinical Study on Rapid Antioxidant Protection and Immune Modulating Effects.

Gitte Jensen, Ph.D. 2021. "Clinical Study on Rapid Antioxidant Protection and Immune Modulating Effects.". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05042674.